Literature DB >> 28631752

Dyslipidaemia: Statin-associated muscle symptoms - really all in the mind?

Robert M Stoekenbroek1, John J P Kastelein1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28631752     DOI： 10.1038/nrcardio.2017.92

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase.

Authors:  Ajay Gupta; David Thompson; Andrew Whitehouse; Tim Collier; Bjorn Dahlof; Neil Poulter; Rory Collins; Peter Sever
Journal:  Lancet       Date:  2017-05-02       Impact factor: 79.321

2.  Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial.

Authors:  Patrick M Moriarty; Paul D Thompson; Christopher P Cannon; John R Guyton; Jean Bergeron; Franklin J Zieve; Eric Bruckert; Terry A Jacobson; Stephen L Kopecky; Marie T Baccara-Dinet; Yunling Du; Robert Pordy; Daniel A Gipe
Journal:  J Clin Lipidol       Date:  2015-08-29       Impact factor: 4.766

3.  Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.

Authors:  Eric Bruckert; Gilles Hayem; Sylvie Dejager; Caroline Yau; Bernard Bégaud
Journal:  Cardiovasc Drugs Ther       Date:  2005-12       Impact factor: 3.727

4.  Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users.

Authors:  Jerome D Cohen; Eliot A Brinton; Matthew K Ito; Terry A Jacobson
Journal:  J Clin Lipidol       Date:  2012 May-Jun       Impact factor: 4.766

5.  Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.

Authors:  Maria-Corina Serban; Lisandro D Colantonio; Angelika D Manthripragada; Keri L Monda; Vera A Bittner; Maciej Banach; Ligong Chen; Lei Huang; Ricardo Dent; Shia T Kent; Paul Muntner; Robert S Rosenson
Journal:  J Am Coll Cardiol       Date:  2017-03-21       Impact factor: 24.094

Review 6.  Interpretation of the evidence for the efficacy and safety of statin therapy.

Authors:  Rory Collins; Christina Reith; Jonathan Emberson; Jane Armitage; Colin Baigent; Lisa Blackwell; Roger Blumenthal; John Danesh; George Davey Smith; David DeMets; Stephen Evans; Malcolm Law; Stephen MacMahon; Seth Martin; Bruce Neal; Neil Poulter; David Preiss; Paul Ridker; Ian Roberts; Anthony Rodgers; Peter Sandercock; Kenneth Schulz; Peter Sever; John Simes; Liam Smeeth; Nicholas Wald; Salim Yusuf; Richard Peto
Journal:  Lancet       Date:  2016-09-08       Impact factor: 79.321

7.  Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.

Authors:  Steven E Nissen; Erik Stroes; Ricardo E Dent-Acosta; Robert S Rosenson; Sam J Lehman; Naveed Sattar; David Preiss; Eric Bruckert; Richard Ceška; Norman Lepor; Christie M Ballantyne; Ioanna Gouni-Berthold; Mary Elliott; Danielle M Brennan; Scott M Wasserman; Ransi Somaratne; Rob Scott; Evan A Stein
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

Review 8.  Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.

Authors:  Erik S Stroes; Paul D Thompson; Alberto Corsini; Georgirene D Vladutiu; Frederick J Raal; Kausik K Ray; Michael Roden; Evan Stein; Lale Tokgözoğlu; Børge G Nordestgaard; Eric Bruckert; Guy De Backer; Ronald M Krauss; Ulrich Laufs; Raul D Santos; Robert A Hegele; G Kees Hovingh; Lawrence A Leiter; Francois Mach; Winfried März; Connie B Newman; Olov Wiklund; Terry A Jacobson; Alberico L Catapano; M John Chapman; Henry N Ginsberg
Journal:  Eur Heart J       Date:  2015-02-18       Impact factor: 29.983

9.  The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability.

Authors:  Robert S Rosenson; Kate Miller; Martha Bayliss; Robert J Sanchez; Marie T Baccara-Dinet; Daniela Chibedi-De-Roche; Beth Taylor; Irfan Khan; Garen Manvelian; Michelle White; Terry A Jacobson
Journal:  Cardiovasc Drugs Ther       Date:  2017-04       Impact factor: 3.727

10.  Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.

Authors:  Dylan L Steen; Irfan Khan; David Ansell; Robert J Sanchez; Kausik K Ray
Journal:  BMJ Open       Date:  2017-02-17       Impact factor: 2.692
  10 in total
  1 in total

1.  Statin dose reduction with complementary diet therapy: A pilot study of personalized medicine.

Authors:  Bianca Scolaro; Marina S Nogueira; Aline Paiva; Adriana Bertolami; Lucia P Barroso; Tomas Vaisar; Sean P Heffron; Edward A Fisher; Inar A Castro
Journal:  Mol Metab       Date:  2018-02-20       Impact factor: 7.422
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.